Médicaments à usage humain – Rapport public européen d’évaluation (EPAR) : Voranigo, vorasidénib, Date d’autorisation : 17/09/2025, Révision : 2, Statut : Autorisé
Voranigo is a cancer medicine used to treat cancers of the brain called astrocytoma or oligodendroglioma in adults and adolescents from 12 years of age who weigh at least 40 kg, ha…
